News UK will leave single market, pharma highlighted as key indus... May sets out plans to leave single market, and aim for EU free trade deal
News New NICE rules could deny drugs to rare disease patients Patients could be denied treatments, says BIA
News Despite Brexit, UK to join EU patent - biotech pleased The UK government has made the surprise to decision to join a new EU single patent and patent court - despite its plans for Brexit.
Views & Analysis UK business fears ‘Hard Brexit’, biotech sets out demands ‘Hard Brexit’ is worrying many businesses, including those in life sciences.
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends